Clinical Trials Browser

OTHER × Interventional × Peritoneal Diseases × Clear all

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

NCT02850874 2022-04-27

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms, Peritoneal Diseases

NCT01523678 2019-07-10

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Phase 2 Completed

108 enrolled

Gynecologic

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Endocrine System Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Urogenital Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT03150992 2019-03-26

EDMONd

Phase NA Unknown

34 enrolled

Gynecologic

Abdominal Neoplasms, Intestinal Obstruction, Neoplasm Metastasis, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms

Clinical Trials

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

EDMONd